TERESA FOGAREN: Open Payments
NPI 1093260093 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$14,820 in 30 payments from 8 companies in 2025. Trend: 2023 $6,209 · 2024 $21,395 · 2025 $14,820
Speaker / faculty: $12,469Travel & lodging: $1,353Food & beverage: $934Education: $64
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $14,581 |
| Legend Biotech USA Inc. | 6 | $104 |
| Celgene Corporation | 1 | $28 |
| Syndax Pharmaceuticals, Inc. | 1 | $25 |
| Caris MPI, Inc. | 1 | $25 |
| BeOne Medicines USA, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| SERVIER PHARMACEUTICALS LLC | 1 | $17 |
Products named: RYBREVANT, CARVYKTI, TECVAYLI, BREYANZI, MI CANCER SEEK, BRUKINSA, Fabhalta, Tibsovo.
Industry payments across MA — which companies pay providers there.
